Skip to main content

letter

. 1982 Apr;45(4):646–647. doi: 10.1038/bjc.1982.103

VLDL-associated mutagenic activity.

M I Gomes, J Rueff, M Halpern

PMCID: PMC2010987 PMID: 7073955

646

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Chan S. Y., Pollard M. Characterization of a very-low-density lipoprotein (VLDL)-associated cytotoxic factor. Br J Cancer. 1981 Sep;44(3):410–417. doi: 10.1038/bjc.1981.199. [DOI] [PMC free article] [PubMed] [Google Scholar]
Chan S. Y., Pollard M. In vitro effects of lipoprotein-associated cytotoxic factor on rat prostate adenocarcinoma cells. Cancer Res. 1978 Sep;38(9):2956–2961. [PubMed] [Google Scholar]
Remsen J. F., Shireman R. B. Effect of low-density lipoprotein on the incorporation of benzo(a)pyrene by cultured cells. Cancer Res. 1981 Aug;41(8):3179–3185. [PubMed] [Google Scholar]
Shu H. P., Nichols A. V. Benzo(a)pyrene uptake by human plasma lipoproteins in vitro. Cancer Res. 1979 Apr;39(4):1224–1230. [PubMed] [Google Scholar]

ACTIONS

RESOURCES